Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction |
|
Medicine details |
|
Medicine name | empagliflozin (Jardiance®) |
Formulation | 10mg, 25mg film coated tablets |
Reference number | 3597 |
Indication | Treatment of symptomatic chronic heart failure with reduced ejection fraction |
Company | Boehringer Ingelheim Ltd |
BNF chapter | Cardiovascular system |
Assessment type | N/A |
Status | Excluded due to NICE appraisal |
Date of issue | 22/06/2021 |
NICE guidance | TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction |